Common variants in CASP3 confer susceptibility to Kawasaki disease.
about
Recent Advances in Kawasaki DiseaseMercury promotes catecholamines which potentiate mercurial autoimmunity and vasodilation: implications for inositol 1,4,5-triphosphate 3-kinase C susceptibility in kawasaki syndromeUnderstanding the pathogenesis of Kawasaki disease by network and pathway analysisGenome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease.Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease.Genetic polymorphisms in Kawasaki disease.Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: A case reportThe roles of Ca2+/NFAT signaling genes in Kawasaki disease: single- and multiple-risk genetic variants.ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.Update of genetic susceptibility in patients with Kawasaki disease.Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studiesCaspase functions in cell death and disease.A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki diseaseAdult Kawasaki disease in a European patient: a case report and review of the literature.A simple, sensitive and safe method to determine the human α/β-tryptase genotypeVariations in ORAI1 Gene Associated with Kawasaki DiseasePathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease.Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)The transcriptional profile of coronary arteritis in Kawasaki diseaseCalcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysisCan a systems biology approach unlock the mysteries of Kawasaki disease?Update on Kawasaki disease: epidemiology, aetiology and pathogenesis.Kawasaki disease: insights into pathogenesis and approaches to treatment.A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.Kawasaki disease: etiopathogenesis and novel treatment strategies.Preventing coronary artery lesions in Kawasaki disease.Sex Differences in Pediatric Rheumatology.Treatment Options for Resistant Kawasaki Disease.The genetics of Kawasaki disease.Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution.Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis.The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies.A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis.Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population.TNF-α blockers for the treatment of Kawasaki disease in childrenCASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese childrenITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease
P2860
Q26775248-8A317FAB-4062-4CBD-9109-A34163D7E626Q26824143-3F6EEB7E-76F5-4929-B577-CAF94125706EQ26996702-D6281BA4-18AF-486B-A214-D80ACDF11781Q29417017-66AA4F24-1FF3-4E3F-851D-89C5FC9AA6AFQ29417090-DAF9DE51-09D0-48EF-9871-679F83711F8DQ31171024-CA4CAA01-AD30-48A2-AE9D-16885C8DD19EQ33566136-7AD3FD31-C583-465B-AB01-495EFEE7627BQ33691319-D791EC4A-16B1-4261-8617-AC0D3B12B1AAQ33718942-3BC5FF5A-AD9F-46C8-A7EC-4D94DF04DAE8Q33886535-6433EE4D-5127-47A0-852D-21F2AC661813Q33960832-652D63C5-FAFD-4FE7-8C94-52457BDE0F96Q34043722-F958086B-178B-4C76-94A8-DC274D07998CQ34085721-2013B346-51A4-4969-B229-17CC55BC9B0EQ34336335-DC94CA14-CD4A-465A-BD50-E2DDD511E9A8Q34874251-559B95FF-BBA3-4ED8-9E70-48B9BB2FA4E6Q35495033-2C021AE6-335C-4A44-A4DE-431E204EBF23Q35535031-0433D4BB-F1F8-48E8-B966-85E2658CC7F9Q35898940-7353C287-37B6-4CA5-9183-220D6FDA60AEQ36305384-EB831CB1-EA81-4AEF-BBCC-821DE608B1CCQ36374231-D72434BF-7C05-4A41-B58C-F37D8202AD56Q36383442-217F2A56-069C-4738-A317-A7F9A9C869C2Q36731339-7065B7F5-0F80-4B95-80FE-0EEE7E08C82AQ37681879-2239FE03-D52F-4AE4-A3D2-D91E716EE5E5Q38071996-B4F3BCC5-F6A8-4DA8-B790-048EA9B9FF81Q38096451-2188BBEE-C049-48A9-8EAC-ACF7D063795AQ38439648-74978729-310B-451F-BCB5-8B68C8973F31Q38601519-2C136AF7-F918-4CF6-AA94-7A7C82097E17Q38945126-09517ECF-BC2A-4906-BD0E-B3747D802480Q39399053-C0D4986B-78A9-42E4-B676-8622560C6C74Q40041622-64CD5D65-6514-40DB-A067-425F0FA4A1C8Q47660588-954788DB-A1BD-4988-9A5C-3DD4A73DB951Q49892043-2626FFF8-F7EE-4D12-A2E9-9CE1CB02EE3AQ50133401-D7331DB9-C43D-4273-8A6D-FBF37D3DE4FAQ50646908-DD4227D1-A8D3-4D1B-8FC4-D45116179E4FQ52817379-9ED2610D-5F24-4B07-A94A-99E3A8018E96Q53107754-A488342C-6C53-422D-88A6-4DFFFDFAFC9CQ54527535-579E29A6-9F50-40C2-9BF6-FAA5740CFAF8Q56759657-BC741639-6476-46EF-912A-8C3E8582D785Q57236144-E814F17F-4F4E-4067-BE04-1E290367A43AQ57269407-4198FCCE-DF34-4D60-ADEF-82930538B214
P2860
Common variants in CASP3 confer susceptibility to Kawasaki disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Common variants in CASP3 confer susceptibility to Kawasaki disease.
@ast
Common variants in CASP3 confer susceptibility to Kawasaki disease.
@en
type
label
Common variants in CASP3 confer susceptibility to Kawasaki disease.
@ast
Common variants in CASP3 confer susceptibility to Kawasaki disease.
@en
prefLabel
Common variants in CASP3 confer susceptibility to Kawasaki disease.
@ast
Common variants in CASP3 confer susceptibility to Kawasaki disease.
@en
P2093
P2860
P50
P356
P1476
Common variants in CASP3 confer susceptibility to Kawasaki disease.
@en
P2093
Akihiro Fujino
Akihito Honda
Anne H Rowley
Annette L Baker
Fumio Kishi
Hiromichi Hamada
Hiroyuki Suzuki
Jane C Buns
Kazunobu Ouchi
Keiko Wakui
P2860
P304
P356
10.1093/HMG/DDQ176
P577
2010-04-27T00:00:00Z